Tuesday, 27 January 2009

Tolperisone




Scheme

Rec.INN

ATC (Anatomical Therapeutic Chemical Classification)

M03BX04

CAS registry number (Chemical Abstracts Service)

0000728-88-1

Chemical Formula

C16-H23-N-O

Molecular Weight

245

Therapeutic Category

Muscle relaxant

Chemical Name

1-Propanone, 2-methyl-1-(4-methylphenyl)-3-(1-piperidinyl)-

Foreign Names

  • Tolperisonum (Latin)
  • Tolperison (German)
  • Tolpérisone (French)
  • Tolperisona (Spanish)

Generic Names

  • Tolperisone (OS: BAN)
  • Mydeton (IS)
  • Tolperisone Hydrochloride (OS: JAN)
  • N-533 (IS)
  • Tolperisone Hydrochloride (PH: JP XIV)

Brand Names

  • Musclex
    Aristopharma, Bangladesh


  • Tolperison
    Terapia, Romania


  • A-Calm
    Acme, Bangladesh


  • Besnoline F
    Kotobuki Seiyaku, Japan


  • Besnoline
    Kotobuki Seiyaku, Japan


  • Menopatol
    Nippon Chemiphar, Japan


  • Miodom
    Dominguez, Argentina


  • Muscalm
    Nippon Kayaku, Japan


  • Muscalm D
    Nippon Kayaku, Japan


  • Muscalm S
    Nippon Kayaku, Japan; Nippon Kayaku, Taiwan


  • Myderison
    Meditop, Hungary


  • Mydeton
    Gedeon Richter, Hungary


  • Mydocalm
    Gedeon Richter, Czech Republic; Gedeon Richter, Georgia; Gedeon Richter, Hong Kong; Gedeon Richter, Lithuania; Gedeon Richter, Latvia; Gedeon Richter, Poland; Gedeon Richter, Romania; Gedeon Richter, Russian Federation; Gedeon Richter, Thailand; Gedeon Richter, Vietnam; Labatec, Switzerland; Richter Gedeon RT, Slovakia; Strathmann, Germany; Taiwan Major, Taiwan


  • Mydocalm (Tolperisone and Lidocaine)
    Richter Gedeon RT, Slovakia


  • Myolax
    Incepta, Bangladesh


  • Nichiperisone
    Nisshin Seiyaku - Yamagata, Japan


  • Tolflex
    Lagap, Switzerland


  • Tolperis
    ICN, Poland


  • Tolperison Hexal
    Hexal, Germany


  • Tolperison-HCl dura
    Mylan dura, Germany


  • Tolperison-HCl Stada
    Stada, Germany


  • Tolperisonhydrochlorid AL
    Aliud, Germany


  • Tolson
    Opsonin, Bangladesh; Opsonin Pharma, Vietnam


  • Toperin
    Eskayef, Bangladesh


  • Topownan
    Tsuruhara, Taiwan; Tsuruhara Seiyaku, Japan


  • Viveo
    Orion, Germany

International Drug Name Search

Glossary

BANBritish Approved Name
ISInofficial Synonym
JANJapanese Accepted Name
OSOfficial Synonym
PHPharmacopoeia Name
Rec.INNRecommended International Nonproprietary Name (World Health Organization)

Click for further information on drug naming conventions and International Nonproprietary Names.

Sunday, 25 January 2009

Lamivudine




In the US, Lamivudine (lamivudine systemic) is a member of the drug class nucleoside reverse transcriptase inhibitors (NRTIs) and is used to treat Hepatitis B, HIV Infection, Nonoccupational Exposure and Occupational Exposure.

US matches:

  • Lamivudine

  • Lamivudine Solution

  • Lamivudine/Zidovudine

  • Lamivudine and zidovudine

  • Lamivudine (3TC)

Scheme

Rec.INN

ATC (Anatomical Therapeutic Chemical Classification)

J05AF05

CAS registry number (Chemical Abstracts Service)

0134678-17-4

Chemical Formula

C8-H11-N3-O3-S

Molecular Weight

229

Therapeutic Category

Antiviral agent, HIV reverse transcriptase inhibitor

Chemical Names

(-)-1-((2R,5S)-2-(Hydroxymethyl)-1,3-oxathiolan-5-yl)cytosine (WHO)

2(1H)-Pyrimidinone, 4-amino-1-[2-(hydroxymethyl)-1,3-oxathiolan-5-yl]-,(2R-cis)-

4-Amino-1-[(2R,5S)-2-(hydroxymethyl)-1,3-oxythiolan-5-yl]pyrimidin-2(1H)-on (IUPAC)

Foreign Names

  • Lamivudinum (Latin)
  • Lamivudin (German)
  • Lamivudine (French)
  • Lamivudina (Spanish)

Generic Names

  • Lamivudine (OS: USAN, DCF, BAN)
  • 3-TC (IS)
  • GR 109714 X (IS: Glaxo)
  • Lamivudine (PH: BP 2010, Ph. Eur. 6, Ph. Int. 4, USP 32)
  • Lamivudinum (PH: Ph. Eur. 6)

Brand Names

  • 3 TC
    GlaxoSmithKline, Argentina


  • 3TC
    GlaxoSmithKline, Australia; GlaxoSmithKline, Aruba; GlaxoSmithKline, Canada; GlaxoSmithKline, Colombia; GlaxoSmithKline, Guyana; GlaxoSmithKline, Hong Kong; GlaxoSmithKline, Indonesia; GlaxoSmithKline, Mexico; GlaxoSmithKline, Malaysia; GlaxoSmithKline, New Zealand; GlaxoSmithKline, Taiwan; GlaxoSmithKline, South Africa; Muscat, Oman; ViiV, Switzerland


  • 3TC-HBV
    GlaxoSmithKline, Indonesia


  • Adco-Lamivudine
    Adcock Ingram Pharmaceuticals, South Africa


  • Amilitrap
    Dosa, Argentina


  • Aspen Lamivudine
    Aspen Pharmacare, South Africa


  • Aspen Lamzid (Lamivudine and Zidovudine)
    Aspen Pharmacare, South Africa


  • Avilam
    Beximco, Bangladesh


  • Avocomb (Lamivudine and Zidovudine)
    Ranbaxy Laboratories, Ethiopia


  • Avolam
    Ranbaxy Laboratories, Ethiopia


  • Ciplabudina
    Biotoscana, Colombia


  • Cipla-Duovir (Lamivudine and Zidovudine)
    Cipla Medpro, South Africa


  • Cipla-Lamivudine
    Cipla Medpro, South Africa


  • Combid (Lamivudine and Zidovudine)
    GlaxoSmithKline, Thailand


  • Combivir (Lamivudine and Zidovudine)
    Bracco, Italy; Glaxo Group, Austria; Glaxo Group, Bulgaria; Glaxo Group, Luxembourg; Glaxo SmithKline, Spain; GlaxoGroup, Netherlands; GlaxoSmithKline, Australia; GlaxoSmithKline, Belgium; GlaxoSmithKline, Bahrain; GlaxoSmithKline, Canada; GlaxoSmithKline, Colombia; GlaxoSmithKline, Germany; GlaxoSmithKline, Denmark; GlaxoSmithKline, Ethiopia; GlaxoSmithKline, Finland; GlaxoSmithKline, France; GlaxoSmithKline, United Kingdom; GlaxoSmithKline, Hong Kong; GlaxoSmithKline, Hungary; GlaxoSmithKline, Ireland; GlaxoSmithKline, Japan; GlaxoSmithKline, Norway; GlaxoSmithKline, New Zealand; GlaxoSmithKline, Oman; GlaxoSmithKline, Peru; GlaxoSmithKline, Sweden; GlaxoSmithKline, Slovenia; GlaxoSmithKline, Slovakia; GlaxoSmithKline, South Africa; ViiV, Switzerland; ViiV Healthcare, United States


  • Coviro (Lamivudine and Stavudine)
    Ranbaxy, Myanmar


  • Diavix (Lamivudine and Zidovudine)
    Beximco, Bangladesh


  • Duovir (Lamivudine and Zidovudine)
    Cipla, Ethiopia


  • Duovox (Lamivudine and Zidovudin)
    Biotoscana, Peru


  • Emduo (Lamivudine and Stavudine)
    Emcure, Myanmar


  • Emtri (Lamivudine and Stavudine, + Nevirapine)
    Emcure, Myanmar


  • Epivir 3TC
    GlaxoSmithKline, Chile; GlaxoSmithKline, Russian Federation


  • Epivir
    Glaxo Group, Austria; Glaxo Group, Luxembourg; Glaxo SmithKline, Spain; Glaxo Wellcome, Portugal; Glaxo Wellcome, Slovenia; Glaxo Wellcome, Tunisia; GlaxoGroup, Netherlands; GlaxoSmithKline, United Arab Emirates; GlaxoSmithKline, Belgium; GlaxoSmithKline, Bahrain; GlaxoSmithKline, Brazil; GlaxoSmithKline, Czech Republic; GlaxoSmithKline, Germany; GlaxoSmithKline, Denmark; GlaxoSmithKline, Ethiopia; GlaxoSmithKline, Finland; GlaxoSmithKline, France; GlaxoSmithKline, United Kingdom; GlaxoSmithKline, Greece; GlaxoSmithKline, Croatia (Hrvatska); GlaxoSmithKline, Hungary; GlaxoSmithKline, Ireland; GlaxoSmithKline, Israel; GlaxoSmithKline, Iran; GlaxoSmithKline, Iceland; GlaxoSmithKline, Italy; GlaxoSmithKline, Japan; GlaxoSmithKline, Kuwait; GlaxoSmithKline, Norway; GlaxoSmithKline, Oman; GlaxoSmithKline, Peru; GlaxoSmithKline, Qatar; GlaxoSmithKline, Romania; GlaxoSmithKline, Serbia; GlaxoSmithKline, Sweden; GlaxoSmithKline, Singapore; GlaxoSmithKline, Slovakia; GlaxoSmithKline, Thailand; GlaxoSmithKline, Turkey; GlaxoSmithKline, Venezuela; ViiV Healthcare, United States


  • Epivir-HBV
    ViiV Healthcare, United States


  • Epzicom (Lamivudine and Abacavir)
    GlaxoSmithKline, Japan; ViiV Healthcare, United States


  • Flamivud
    Flamingo Pharmacueticals, Ethiopia


  • Ganvirel
    Ivax, Argentina


  • Hepadin
    Amico, Bangladesh


  • Hepavir
    Square, Bangladesh


  • Hepitec
    GlaxoSmithKline, India


  • Heptodin
    GlaxoSmithKline, China


  • Heptodine
    GlaxoSmithKline, Argentina


  • Heptovir
    GlaxoSmithKline, Canada


  • Hivarif
    Square, Bangladesh


  • Imunoxa
    Gador, Argentina


  • Inhavir
    Biogen, Colombia; Biogen, Peru


  • Kess
    Filaxis, Argentina


  • Kivexa (Lamivudine and Abacavir)
    Glaxo Group, Austria; Glaxo SmithKline, Spain; GlaxoGroup, Netherlands; GlaxoSmithKline, Australia; GlaxoSmithKline, Belgium; GlaxoSmithKline, Canada; GlaxoSmithKline, Germany; GlaxoSmithKline, Denmark; GlaxoSmithKline, France; GlaxoSmithKline, United Kingdom; GlaxoSmithKline, Greece; GlaxoSmithKline, Croatia (Hrvatska); GlaxoSmithKline, Hungary; GlaxoSmithKline, Ireland; GlaxoSmithKline, Italy; GlaxoSmithKline, Norway; GlaxoSmithKline, New Zealand; GlaxoSmithKline, Portugal; GlaxoSmithKline, Sweden; GlaxoSmithKline, Slovenia; GlaxoSmithKline, South Africa; ViiV, Switzerland


  • Ladiwin
    Cadila, Ghana; Cadila, Kenya; Cadila, Malawi; Cadila, Nigeria; Cadila, Sudan; Cadila, Tanzania; Cadila, Uganda; Cadila, Zambia; Cadila Health Care, Ethiopia; Zydus Cadila, India


  • Lamibergen
    Paylos, Argentina


  • Lamidac
    Cadila Health Care, Ethiopia; Zydus Cadila, India; Zydus Cadila, Myanmar


  • Lamidin
    Eskayef, Bangladesh; Medibios Laboratories, Ethiopia


  • Lamilea
    Elea, Argentina


  • Lamimac
    Macleods Pharmaceuticals, Ethiopia


  • Lamitec
    Zifam India, Myanmar


  • Lamitec-S (Lamivudine and Stavudine)
    Zifam India, Myanmar


  • Lamivir
    Cipla, Georgia; Cipla, India; Flamingo Pharmacueticals, Ethiopia; Incepta, Bangladesh; Pharmaceutical, Venezuela


  • Lamivox
    Aurobindo Pharma, Ethiopia; Biotoscana, Peru


  • Lamivudin Stada
    Stada, Vietnam


  • Lamivudina Delta
    Delta Farma, Argentina


  • Lamivudina Microsules
    Microsules, Argentina


  • Lamivudina
    Induquimica, Peru


  • Lamivudine
    InvaGen, United States


  • Lamivur
    Cipla, Ethiopia


  • Lamuzid (Lamivudine and Zidovudine)
    Cadila Health Care, Ethiopia; Zydus Cadila, Myanmar


  • Lasovir (Lamivudine and Zidovudine)
    Zifam India, Myanmar


  • Lavir
    Emcure, Myanmar


  • Lazid (Lamivudine and Stavudine)
    Emcure, Myanmar


  • Maxivir (Lamivudine and Stavudine, + Nevirapine)
    Okasa, Myanmar


  • Medilam (Lamivudine and Stavudine)
    Meditab, Myanmar


  • Medivir (Lamivudine and Zidovudine)
    Meditab, Myanmar


  • Oralmuv
    LKM, Argentina


  • Sonke-LamiNevStav (Lamivudine and Nevirapine, + Stavudine)
    Ranbaxy, South Africa


  • Sonke-Lamivudine + Zidovudine (Lamivudine and Zidovudine)
    Ranbaxy, South Africa


  • Sonke-Lamivudine
    Ranbaxy, South Africa


  • Triomune (Lamivudine and Stavudine, + Nevirapine)
    Cipla Medpro, South Africa


  • Triovix (Lamivudine and Zidovudine)
    Beximco, Bangladesh


  • Trizivir (Lamivudine and Abacavir, + Zidovudine)
    Glaxo Group, Austria; Glaxo SmithKline, Spain; Glaxo Wellcome, Bulgaria; GlaxoGroup, Netherlands; GlaxoSmithKline, Australia; GlaxoSmithKline, Belgium; GlaxoSmithKline, Canada; GlaxoSmithKline, Colombia; GlaxoSmithKline, Germany; GlaxoSmithKline, France; GlaxoSmithKline, United Kingdom; GlaxoSmithKline, Ireland; GlaxoSmithKline, Norway; GlaxoSmithKline, Oman; GlaxoSmithKline, Sweden; GlaxoSmithKline, Turkey; GlaxoSmithKline, South Africa; Novo Nordisk, Denmark; Shire, Canada; ViiV, Switzerland; ViiV Healthcare, United States


  • Trovir (Lamivudine and Zidovudine, + Nevirapine)
    Zifam India, Myanmar


  • Viradin
    Healthcare, Bangladesh


  • Virdual (Lamivudine and Zidovudine)
    Biogen, Colombia


  • Virocomb (Lamivudine and Zidovudine)
    Ranbaxy, Myanmar


  • Virocomb-N (Lamivudine and Nevirapine, + Zidovudine)
    Ranbaxy, Myanmar


  • Virolans (Lamivudine and Nevirapine, + Stavudine)
    Ranbaxy, Myanmar


  • Virozen (Lamivudine and Stavudine, + Nevirapine)
    Zifam India, Myanmar


  • Vuclodir
    Richmond, Argentina; Richmond, Peru


  • Vudin
    Alco, Bangladesh


  • Zeffix
    Glaxo Group, Austria; Glaxo Group, Luxembourg; Glaxo Group, Poland; Glaxo Group Limited-GB, Italy; Glaxo SmithKline, Spain; Glaxo Wellcome, Portugal; Glaxo Wellcome, Slovenia; Glaxo Wellcome, Tunisia; GlaxoGroup, Netherlands; GlaxoSmithKline, Australia; GlaxoSmithKline, Bosnia & Herzegowina; GlaxoSmithKline, Bangladesh; GlaxoSmithKline, Belgium; GlaxoSmithKline, Switzerland; GlaxoSmithKline, Czech Republic; GlaxoSmithKline, Germany; GlaxoSmithKline, Denmark; GlaxoSmithKline, Finland; GlaxoSmithKline, France; GlaxoSmithKline, United Kingdom; GlaxoSmithKline, Greece; GlaxoSmithKline, Hong Kong; GlaxoSmithKline, Croatia (Hrvatska); GlaxoSmithKline, Hungary; GlaxoSmithKline, Ireland; GlaxoSmithKline, Israel; GlaxoSmithKline, Sri Lanka; GlaxoSmithKline, Myanmar; GlaxoSmithKline, Malaysia; GlaxoSmithKline, Norway; GlaxoSmithKline, New Zealand; GlaxoSmithKline, Oman; GlaxoSmithKline, Philippines; GlaxoSmithKline, Romania; GlaxoSmithKline, Serbia; GlaxoSmithKline, Russian Federation; GlaxoSmithKline, Sweden; GlaxoSmithKline, Singapore; GlaxoSmithKline, Slovakia; GlaxoSmithKline, Thailand; GlaxoSmithKline, Turkey; GlaxoSmithKline, Taiwan; GlaxoSmithKline, Vietnam


  • Zefix
    GlaxoSmithKline, Japan

International Drug Name Search

Glossary

BANBritish Approved Name
DCFDénomination Commune Française
IUPACInternational Union of Pure and Applied Chemistry
ISInofficial Synonym
OSOfficial Synonym
PHPharmacopoeia Name
Rec.INNRecommended International Nonproprietary Name (World Health Organization)
USANUnited States Adopted Name
WHOWorld Health Organization

Click for further information on drug naming conventions and International Nonproprietary Names.

Friday, 23 January 2009

Supositorios Glicerina Glycilax




Supositorios Glicerina Glycilax may be available in the countries listed below.


Ingredient matches for Supositorios Glicerina Glycilax



Glycerol

Glycerol is reported as an ingredient of Supositorios Glicerina Glycilax in the following countries:


  • Spain

International Drug Name Search

Thursday, 22 January 2009

Innohep




In the US, Innohep (tinzaparin systemic) is a member of the drug class heparins and is used to treat Deep Vein Thrombosis.

US matches:

  • Innohep

UK matches:

  • Innohep 10,000 IU/ML
  • Innohep 20,000 IU/ML
  • Innohep syringe 10,000 IU/ML
  • Innohep syringe 20,000 IU/ML
  • Innohep 10,000 IU/ml and Innohep Syringe 10,000 IU/ml (SPC)
  • Innohep 20,000 IU/ml and Innohep syringe 20,000 IU/ml (SPC)

Ingredient matches for Innohep



Tinzaparin

Tinzaparin Sodium is reported as an ingredient of Innohep in the following countries:


  • Bahrain

  • Belgium

  • Bulgaria

  • Canada

  • Denmark

  • France

  • Germany

  • Greece

  • Hong Kong

  • Ireland

  • Israel

  • Luxembourg

  • Malaysia

  • Netherlands

  • New Zealand

  • Oman

  • Philippines

  • Portugal

  • Romania

  • Singapore

  • Spain

  • Sri Lanka

  • Sweden

  • Thailand

  • Tunisia

  • Turkey

  • United Kingdom

  • United States

International Drug Name Search

Glossary

SPC Summary of Product Characteristics (UK)

Click for further information on drug naming conventions and International Nonproprietary Names.

Sunday, 18 January 2009

Domperidon Stada




Domperidon Stada may be available in the countries listed below.


Ingredient matches for Domperidon Stada



Domperidone

Domperidone maleate (a derivative of Domperidone) is reported as an ingredient of Domperidon Stada in the following countries:


  • Germany

International Drug Name Search

Tuesday, 13 January 2009

Dazidox


Generic Name: oxycodone (ox i KOE done)

Brand Names: Dazidox, OxyCONTIN, Oxyfast, OxyIR, Percolone, Roxicodone, Roxicodone Intensol


What is Dazidox (oxycodone)?

Oxycodone is a narcotic pain reliever similar to morphine.


Oxycodone is used to treat moderate to severe pain. The extended-release form of this medication is for around-the-clock treatment of pain.


Oxycodone may also be used for purposes not listed in this medication guide.


What is the most important information I should know about Dazidox (oxycodone)?


Oxycodone may be habit-forming and should be used only by the person it was prescribed for. Keep the medication in a secure place where others cannot get to it. Do not drink alcohol while you are taking oxycodone. Dangerous side effects or death can occur when alcohol is combined with a narcotic pain medicine. Check your food and medicine labels to be sure these products do not contain alcohol. Never take oxycodone in larger amounts, or for longer than recommended by your doctor. Follow the directions on your prescription label. Tell your doctor if the medicine seems to stop working as well in relieving your pain. This medication may impair your thinking or reactions. Be careful if you drive or do anything that requires you to be alert. Do not stop using oxycodone suddenly, or you could have unpleasant withdrawal symptoms. Ask your doctor how to avoid withdrawal symptoms when you stop using oxycodone.

What should I discuss with my healthcare provider before using Dazidox (oxycodone)?


Do not use this medication if you have ever had an allergic reaction to a narcotic medicine (examples include methadone, morphine, Oxycontin, Darvocet, Percocet, Vicodin, Lortab, and many others), or to a narcotic cough medicine that contains codeine, hydrocodone, or dihydrocodeine.

You should also not take oxycodone if you are having an asthma attack or if you have a bowel obstruction called paralytic ileus.


Oxycodone may be habit forming and should be used only by the person it was prescribed for. Never share oxycodone with another person, especially someone with a history of drug abuse or addiction. Keep the medication in a place where others cannot get to it.

To make sure you can safely take oxycodone, tell your doctor if you have any of these other conditions:



  • asthma, COPD, sleep apnea, or other breathing disorders;



  • liver or kidney disease;


  • underactive thyroid;




  • trouble swallowing, or a blockage in your digestive tract (stomach or intestines);




  • curvature of the spine;




  • a history of head injury or brain tumor;




  • epilepsy or other seizure disorder;




  • low blood pressure;




  • gallbladder disease;




  • Addison's disease or other adrenal gland disorders;




  • enlarged prostate, urination problems;




  • mental illness; or




  • a history of drug or alcohol addiction.




FDA pregnancy category B. Oxycodone is not expected to harm an unborn baby. Tell your doctor if you are pregnant or plan to become pregnant during treatment. Oxycodone can pass into breast milk and may harm a nursing baby. You should not breast-feed while you are using oxycodone. Older adults may be more likely to have side effects from this medicine.

How should I use Dazidox (oxycodone)?


Take exactly as prescribed. Never take oxycodone in larger amounts, or for longer than recommended by your doctor. Follow the directions on your prescription label. Tell your doctor if the medicine seems to stop working as well in relieving your pain.


Do not crush, chew, or break an extended-release tablet. Swallow it whole. Breaking the pill may cause too much of the drug to be released at one time. If your doctor has told you to take two or more oxycodone tablets per dose, take the tablets one at a time. Do not wet, presoak, or lick the tablet before placing it in your mouth. Drink plenty of water to make swallowing easier and to prevent choking.

Measure the liquid form of oxycodone with a special dose-measuring spoon or cup, not a regular table spoon. If you do not have a dose-measuring device, ask your pharmacist where you can get one.


Drink plenty of water daily to help prevent constipation while you are using oxycodone. Ask your doctor about ways to increase the fiber in your diet. Do not use a stool softener (laxative) without first asking your doctor.


Do not stop using oxycodone suddenly after long-term use, or you could have unpleasant withdrawal symptoms. Ask your doctor how to avoid withdrawal symptoms when you stop using oxycodone.

Never crush a tablet or other pill to mix into a liquid for injecting the drug into your vein. This practice has resulted in death with the misuse of oxycodone and similar prescription drugs.


Store at room temperature, away from heat, moisture, and light.

Keep track of the amount of medicine used from each new bottle. Oxycodone is a drug of abuse and you should be aware if anyone is using your medicine improperly or without a prescription.


Always check your bottle to make sure you have received the correct pills (same brand and type) of medicine prescribed by your doctor. Ask the pharmacist if you have any questions about the medicine you receive at the pharmacy.


After you have stopped using this medication, flush any unused pills down the toilet. Throw away any unused liquid oxycodone that is older than 90 days.


What happens if I miss a dose?


Since oxycodone is taken as needed, you may not be on a dosing schedule. If you are taking the medication regularly, take the missed dose as soon as you remember. Skip the missed dose if it is almost time for your next scheduled dose. Do not take extra medicine to make up the missed dose.


Extended-release oxycodone is not for use on an as-needed basis for pain.

What happens if I overdose?


Seek emergency medical attention or call the Poison Help line at 1-800-222-1222. An overdose of oxycodone can be fatal.

Overdose symptoms may include extreme drowsiness, muscle weakness, confusion, cold and clammy skin, pinpoint pupils, shallow breathing, slow heart rate, fainting, or coma.


What should I avoid while using Dazidox (oxycodone)?


Do not drink alcohol while you are taking this medication. Dangerous side effects or death can occur when alcohol is combined with oxycodone. Check your food and medicine labels to be sure these products do not contain alcohol. Oxycodone may impair your thinking or reactions. Be careful if you drive or do anything that requires you to be alert.

Dazidox (oxycodone) side effects


Get emergency medical help if you have any of these signs of an allergic reaction: hives; difficulty breathing; swelling of your face, lips, tongue, or throat. Stop using oxycodone and call your doctor at once if you have a serious side effect such as:

  • shallow breathing, slow heartbeat;




  • seizure (convulsions);




  • cold, clammy skin;




  • confusion;




  • severe weakness or dizziness; or




  • feeling like you might pass out.



Less serious side effects are more likely to occur, such as:



  • nausea, vomiting, constipation, loss of appetite;




  • dizziness, headache, tired feeling;




  • dry mouth;




  • sweating; or




  • itching.



This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.


What other drugs will affect Dazidox (oxycodone)?


Before using oxycodone, tell your doctor if you regularly use other medicines that make you sleepy or slow your breathing (such as cold or allergy medicine, sedatives, narcotic pain medicine, sleeping pills, muscle relaxers, and medicine for seizures, depression, or anxiety). Dangerous side effects may result.

Tell your doctor about all other medicines you use, especially:



  • pentazocine (Talwin);




  • nalbuphine (Nubain);




  • butorphanol (Stadol); or




  • buprenorphine (Buprenex, Subutex).



This list is not complete and other drugs may interact with oxycodone. Tell your doctor about all medications you use. This includes prescription, over-the-counter, vitamin, and herbal products. Do not start a new medication without telling your doctor.



More Dazidox resources


  • Dazidox Side Effects (in more detail)
  • Dazidox Use in Pregnancy & Breastfeeding
  • Dazidox Drug Interactions
  • Dazidox Support Group
  • 0 Reviews for Dazidox - Add your own review/rating


  • Dazidox Advanced Consumer (Micromedex) - Includes Dosage Information

  • OxyContin Sustained-Release Tablets MedFacts Consumer Leaflet (Wolters Kluwer)

  • OxyContin Prescribing Information (FDA)

  • Oxycodone Monograph (AHFS DI)

  • Oxycodone MedFacts Consumer Leaflet (Wolters Kluwer)

  • Oxycodone Prescribing Information (FDA)

  • Oxycontin Consumer Overview

  • Oxyfast Concentrate MedFacts Consumer Leaflet (Wolters Kluwer)

  • Roxicodone Prescribing Information (FDA)



Compare Dazidox with other medications


  • Pain


Where can I get more information?


  • Your pharmacist can provide more information about oxycodone.

See also: Dazidox side effects (in more detail)


Saturday, 10 January 2009

Ramipril / HCT Sandoz




Ramipril/HCT Sandoz may be available in the countries listed below.


Ingredient matches for Ramipril/HCT Sandoz



Hydrochlorothiazide

Hydrochlorothiazide is reported as an ingredient of Ramipril/HCT Sandoz in the following countries:


  • Austria

  • Germany

Ramipril

Ramipril is reported as an ingredient of Ramipril/HCT Sandoz in the following countries:


  • Austria

  • Germany

International Drug Name Search

Wednesday, 7 January 2009

Doxycyclin Basics




Doxycyclin Basics may be available in the countries listed below.


Ingredient matches for Doxycyclin Basics



Doxycycline

Doxycycline monohydrate (a derivative of Doxycycline) is reported as an ingredient of Doxycyclin Basics in the following countries:


  • Germany

International Drug Name Search

Tuesday, 6 January 2009

Doccelipro




Doccelipro may be available in the countries listed below.


Ingredient matches for Doccelipro



Celiprolol

Celiprolol hydrochloride (a derivative of Celiprolol) is reported as an ingredient of Doccelipro in the following countries:


  • Luxembourg

International Drug Name Search

Sunday, 4 January 2009

Dermexane




Dermexane may be available in the countries listed below.


Ingredient matches for Dermexane



Clobetasol

Clobetasol 17α-propionate (a derivative of Clobetasol) is reported as an ingredient of Dermexane in the following countries:


  • Argentina

International Drug Name Search